New cancer drug enters human testing for Tough-to-Treat tumors
Disease control
Recruiting now
This is the first human study of an experimental drug called PLB-002 for adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and understand how the drug behaves in the body. The study will enroll about 100 …
Phase: PHASE1 • Sponsor: Primelink BioTherapeitics(ShenZhen) Limited • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC